under the microscope
under the microscope
· Nov 2019
This is the first new treatment to reach the market in almost 20 years. The drug uses a completely different pathway than any before it. It “is suggested to reduce neuroinflammation by modulating a person’s gut microbiome.” After a 9-month Phase III clinical trial the drug was approved with some limitations. There’s still a healthy dose of skepticism around it’s long-term value, though. | learn more
under the microscope
· Nov 2019
“New research has for the first time demonstrated how exposure to Narrow Band Ultraviolet B light (UVB) can directly influence gut microbiome diversity in humans.” | learn more
under the microscope
· Nov 2019
“Humanity is poised to take a huge leap forward, as a convergence of next-gen technologies combine to give us unprecedented power over our own biology. Here’s a roadmap to the key technologies and how it’s going to play out in the coming decades.” | learn more
under the microscope
· Oct 2019
New evidence from a longitudinal study reinforces the link (correlation, not causation) between walking speed and brain health. | learn more
under the microscope
· Oct 2019
I’d say this is one of the most interesting trends I’m tracking right now. “Laboratory-automation start-ups are borrowing a page from the software industry.” | learn more
under the microscope
· Oct 2019
“Humans may not be able to regrow amputated limbs like salamanders can – but we do have a ‘salamander-like’ ability to regrow damaged cartilage, a new study has found.” | learn more
under the microscope
· Oct 2019
They acknowledge that agents like psilocybin can be really useful, but wish they could use them without the pesky “deleterious neurological effects.“ | learn more
under the microscope
· Oct 2019
“CBD is being hailed as a cure-all, but what does it do? Jeffrey Chen, executive director of the UCLA Cannabis Research Initiative, explains.” | learn more
under the microscope
· Sep 2019
“The effects of exercise on insulin secretion, the role of exercise-induced energy deficit, and possible dose–response relationships are not well understood. This study aimed to evaluate insulin sensitivity and insulin secretion after progressively greater negative energy balance induced by exercise or diet.” | learn more
under the microscope
· Sep 2019
I’ve been referencing this Kahneman study in many conversations over the past couple month, so I thought I’d link to it here. After exposing subjects to two versions of a painful stimulus and asking which they wanted to repeat, “A significant majority chose to repeat the long trial, apparently preferring more pain over less.” | learn more